These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6115730)

  • 1. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor.
    Pickles H; Perucca E; Fish A; Richens A
    Clin Pharmacol Ther; 1981 Sep; 30(3):303-10. PubMed ID: 6115732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentrations and the time-course of beta blockade due to propranolol.
    McDevitt DG; Shand DG
    Clin Pharmacol Ther; 1975 Dec; 18(6):708-13. PubMed ID: 1169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of the nitroglycerin test.
    Zweifler AJ; Hansson L
    Clin Pharmacol Ther; 1976 Apr; 19(4):403-9. PubMed ID: 817856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of exercise conditioning by low dose beta-adrenergic receptor blockade.
    Marsh RC; Hiatt WR; Brammell HL; Horwitz LD
    J Am Coll Cardiol; 1983 Sep; 2(3):551-6. PubMed ID: 6135725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflex vagal withdrawal and the hemodynamic response to intravenous isoproterenol in the presence of beta-antagonists.
    Arnold JM; McDevitt DG
    Clin Pharmacol Ther; 1986 Aug; 40(2):199-208. PubMed ID: 3015474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.